| Hydrocodone Bitartrate | PERNIX IRELAND | ||
| 10,15,20,30,40,50 mg; Capsule, Extended Release |
Less Than $1000 mn
|
||
|
Less Than 5
|
Less Than 5
|
||
| None |
Less Than 5
|
||
|
Less Than 5
|
Less Than 5
|
||
| Indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. | |||
|
Yes
| |||
| Zohydro ER | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 | Patent 13 | Patent 14 | Patent 15 | Patent 16 | Patent 17 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* |
| ******* | ******* | ******* | ******* | ******* ***** *** ** ** | ******* | ******* | ******* ***** *** ** ** | **** ** *** **, **** | **** ** *** **, **** | *** ********* | *** ********* | *** ********* | *** ********* | *** ********* | *** ********* | *** ********* | *** ********* |
| ******** **** ** ******** **** ******* ********** | ***** ********* ************** ************ | ******** **** ** ******** **** ******* ********** | ******** **** ** ******** **** ******* ********** | **************** ******** ******* *********** | **************** ******** ******* *********** | ***** ********* ************** ************ | ******** **** ** ******** **** ******* ********** | ******** **** ** ******** **** ******* ********** | ******** **** ** ******** **** ******* ********** | ******** **** ** ******** **** ******* ********** | ******** **** ** ******** **** ******* ********** | ******** **** ** ******** **** ******* ********** | ***** ********* ************** ************ | ***** ********* ************** ************ | ******** **** ** ******** **** ******* ********** | ***** ********* ************** ************ |
| Company | FTF Status / 180 days exclusivity | 30-Months stay | Current Litigation Status | Current Approval Status | Likelihood of launch |
|---|---|---|---|---|---|
| ******* | *** \ ** | ***** *, **** | ******* | ********* ******** | ** ***** *, **** |
| ******* | *** \ ** | ***** *, **** | **** ******* *** ** ** | ******** | ******** ** *** **, **** |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|